Major Hospitals
AI Accuracy
Global Standard
Established
PurpleAI is a medical AI company redefining acute stroke care — from faster detection to predictive foresight. Founded as an independent company in October 2024 after five years of R&D within SK Group, PurpleAI is deployed in numerous Korean university hospitals and expanding into the U.S. market with FDA-cleared technology. Our mission: give clinicians the speed, accuracy, and predictive insight they need to intervene earlier and improve patient outcomes in acute stroke care.
Our Hyper Insight™ platform delivers FDA-cleared, real-time stroke detection in seconds. StrokeShieldAI™, our predictive analytics platform in development, forecasts high-risk complications during acute stroke care — before they manifest clinically.
Stroke care today is reactive. PurpleAI is building toward a future where it is predictive. By combining proven real-time triage with multimodal, data-driven risk modeling, we aim to shift the standard of care from detection-after-the-fact to anticipation-before-deterioration — enabling earlier intervention across the full continuum of acute neurovascular care. Detect Now. Predict What's Next.
Milestones